Objectives: To assess the received suspected adverse events occurring upon treatment with drugs and vaccines, at National Centre for Pharmacovigilance, in Togo, from 2009 to 2016. Methods: A crossover study was conduc...
funded by General Program of National Natural Science Foundation of China(NO.81473798):Study on allergic reaction mechanism of post-marketing Chinese medicine injections with active monitoring and network target monitoring;National Science and Technology Major Project of"Development Program of Significant New Drug"(2015ZX09501004-001-002/009);Entrusted Project of China Center for Food and Drug International Exchange,The State Food and Drug Administration:International promotion of Chinese medicine safety
With the widespread concern about the safety of Chinese materia medica, China urgently needs to build a Chinese materia medica pharmacovigilance system that conforms to the national development policy and has the char...
Background: The inappropriate, irrational use or misuse of antibiotics is observed in all health systems and in all patients’ groups worldwide, especially for children, where antibiotics continue to be the drugs most...
Background: Dialyzable leukocyte extracts (DLE) are heterogeneous mixtures of peptides less than 10 kDa in size that are used as immunomodulatory adjuvants in immune-mediated diseases. TransferonTM is DLE manufactured...
Objective: The reports submitted to the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) from 1997 to 2011 were reviewed to assess the gender effects on muscular adverse events induced by t...
support given by the research project HR-QoD - Quality of data (outliers, inconsistencies and errors) in hospital inpatient databases: methods and implications for data modeling, cleansing and analysis (project PTDC/SAUESA/75660/2006)
AIM: To detect ophthalmic adverse drug reactions(ADRs), that occurred in Portugal from 2000 to 2009, through the utilization of administrative hospital databases. We also intended to compare the results of this method...